Trials / Unknown
UnknownNCT03538704
Effect of Fertility-sparing Therapy of Early Endometrial Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of Fertility-sparing Therapy of Early Endometrial Cancer.
Detailed description
This is a prospective, multi center, open, randomized, controlled clinical trial. All endometrial cancer (EC) or atypical hyperplasia (AH) patients who met the fertility-sparing indications in the hospitals involved in this study were recruited. Then the investigators conducted assessment, treatment and follow up according to the standard procedure. General information, therapeutic regimen, side effects, oncological and pregnant results were collected for risk factors analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | Metformin is given to patients 1-1.5g/d. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2020-03-31
- Completion
- 2020-12-31
- First posted
- 2018-05-29
- Last updated
- 2018-05-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03538704. Inclusion in this directory is not an endorsement.